SEC Comment Letter 0000000000-24-005808 to Orchestra BioMed Holdings, Inc. (OBIO) (CIK 0001814114) (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO) (CIK 0001814114)
Date: May 20, 2024 · CIK: 0001814114 · Accession: 0000000000-24-005808
AI Filing Summary & Sentiment
File numbers found in text: 333-279430
Letter
United States securities and exchange commission logo May 20, 2024 David Hochman Chief Executive Officer Orchestra BioMed Holdings, Inc. 150 Union Square Drive New Hope, PA 18938 Re:Orchestra BioMed Holdings, Inc. Registration Statement on Form S-3 Filed May 15, 2024 File No. 333-279430 Dear David Hochman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Keith Pisani, Esq.
Show Raw Text
United States securities and exchange commission logo
May 20, 2024
David Hochman
Chief Executive Officer
Orchestra BioMed Holdings, Inc.
150 Union Square Drive
New Hope, PA 18938
Re:Orchestra BioMed Holdings, Inc.
Registration Statement on Form S-3
Filed May 15, 2024
File No. 333-279430
Dear David Hochman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Keith Pisani, Esq.